Resuscitation Fluid Choice and Clinical Outcomes

Acute Kidney Injury Clinical Trial

Official title:

Association of Resuscitation Fluid Choice and Clinical Outcomes in Critically Ill Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02641119
• Other study ID #: PRO13120333
• Status: Completed
• Start date: August 2014
• Est. completion date: August 2018

Study information

• Verified date: November 2018
• Source: University of Pittsburgh
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This observational study evaluates the potential benefits, costs and clinical outcomes of albumin over saline and other non-saline fluids in patients receiving large volume resuscitation.

Description:

Currently, recommended resuscitation paradigms involve a "crystalloid-first" approach. This approach reserves more potent and potentially more toxic colloids for patients that have already been exposed to large amounts of crystalloid and may have also experienced a delay in correcting their shock.

This observational retrospective cohort study aims to identify predictors for large volume resuscitation (LVR) and model the potential benefits, costs and clinical outcomes of albumin over saline and other non-saline fluids in patients receiving large volume resuscitation. Further analyses will assess the risk of acute kidney injury (AKI) and hyperchloremic metabolic acidosis (HCA) associated with resuscitation fluid choice and examine long term outcomes such as development of end stage renal disease and post-discharge mortality up to 1 year following hospital discharge in patients treated with various fluid types

This study will utilize data in a large, heterogeneous cohort (n=~65,800) of critically ill patients admitted to the ICU over a 12 year period at the University of Pittsburgh Medical Center. The study population will consist of patients who receive large volume resuscitation (defined as > 60ml/kg in a single 24 hour period) separated into analysis groups based on fluids administered during the defined 24 hour large volume resuscitation window. Patients presenting with AKI or HCA prior to large volume resuscitation will be excluded. AKI and "Severe" AKI will be diagnosed based on KDIGO criteria within 72 hours following LVR. Metabolic acidosis will be based on arterial blood gas measurements with a base deficit > 2 mEq/l, with patients having chloride as the ion contributing to the majority of the acidosis being diagnosed with Hyperchloremic metabolic acidosis. Mortality at 30, 90, and 365-days from ICU admission will be ascertained using the social security death master file. Propensity score models will be used to determine the adjusted relationship between these clinical outcomes and type of fluid resuscitation employed.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 65800
• Est. completion date: August 2018
• Est. primary completion date: January 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Critically ill patient admitted to ICU

Exclusion Criteria:

• History of chronic dialysis and/or renal transplant

• Baseline serum creatinine >= 4 mg/dl

• Develop AKI or MA prior to LVR

• Received OR fluids during LVR

Related Conditions & MeSH terms

• Acidosis
• Acute Kidney Injury
• Hyperchloremic Metabolic Acidosis
• Large Volume Resuscitation

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University of Pittsburgh

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Mortality	Number of patients who die prior to hospital discharge	Prior to hospital discharge. Expected length of inpatient stay is 30 days.
Secondary	Development of Acute Kidney Injury (AKI)	Number of patients who develop AKI within 72 hours following large volume resuscitation	Within 72 hours following large volume resuscitation
Secondary	Development of Hyperchloremic metabolic acidosis	Number of patients who develop Hyperchloremic metabolic acidosis within 24 hours following large volume resuscitation	Within 24 hours following large volume resuscitation
Secondary	Mortality	Number of patients who die within 1 year from ICU admission	1 year from ICU admission